DE60206775D1 - Agonisten für den adenosin a3 rezeptor - Google Patents
Agonisten für den adenosin a3 rezeptorInfo
- Publication number
- DE60206775D1 DE60206775D1 DE60206775T DE60206775T DE60206775D1 DE 60206775 D1 DE60206775 D1 DE 60206775D1 DE 60206775 T DE60206775 T DE 60206775T DE 60206775 T DE60206775 T DE 60206775T DE 60206775 D1 DE60206775 D1 DE 60206775D1
- Authority
- DE
- Germany
- Prior art keywords
- adenosine
- agonists
- receptor
- neutropennia
- leukopenia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31106901P | 2001-08-08 | 2001-08-08 | |
US311069P | 2001-08-08 | ||
PCT/US2002/024696 WO2003014137A1 (en) | 2001-08-08 | 2002-08-06 | Adenosine a3 receptor agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60206775D1 true DE60206775D1 (de) | 2006-03-02 |
DE60206775T2 DE60206775T2 (de) | 2006-07-20 |
Family
ID=23205248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60206775T Expired - Lifetime DE60206775T2 (de) | 2001-08-08 | 2002-08-06 | Agonisten für den adenosin a3 rezeptor |
Country Status (20)
Country | Link |
---|---|
US (1) | US20030078232A1 (de) |
EP (1) | EP1414837B1 (de) |
JP (1) | JP4357960B2 (de) |
KR (1) | KR100923888B1 (de) |
CN (1) | CN1244589C (de) |
AT (1) | ATE307136T1 (de) |
AU (1) | AU2002327426C1 (de) |
CA (1) | CA2456744A1 (de) |
DE (1) | DE60206775T2 (de) |
DK (1) | DK1414837T3 (de) |
ES (1) | ES2247371T3 (de) |
HU (1) | HUP0401437A3 (de) |
IL (2) | IL160231A0 (de) |
MX (1) | MXPA04001185A (de) |
NO (1) | NO327997B1 (de) |
NZ (1) | NZ530976A (de) |
PL (1) | PL368205A1 (de) |
RU (1) | RU2298557C2 (de) |
WO (1) | WO2003014137A1 (de) |
ZA (1) | ZA200401000B (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7427606B2 (en) | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
US7378400B2 (en) | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
JP4310109B2 (ja) * | 2001-04-26 | 2009-08-05 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾリル基を置換基として有する含窒素縮合環化合物およびその医薬組成物 |
SG176313A1 (en) | 2001-10-01 | 2011-12-29 | Univ Virginia Patent Found | 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
ES2333651T3 (es) * | 2002-09-09 | 2010-02-25 | Cv Therapeutics, Inc. | Agonistas del receptor de adenosina a3. |
WO2004086034A2 (en) * | 2003-03-28 | 2004-10-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a3(adora3) |
WO2005012256A1 (en) | 2003-07-22 | 2005-02-10 | Astex Therapeutics Limited | 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
WO2006023272A1 (en) | 2004-08-02 | 2006-03-02 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
WO2006028618A1 (en) | 2004-08-02 | 2006-03-16 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
CA2585581A1 (en) * | 2004-11-22 | 2006-05-26 | King Pharmaceuticals Research & Development Inc. | Enhancing treatment of hif-1 mediated disorders with adenosine a3 receptor agonists |
MX2007008781A (es) | 2005-01-21 | 2007-09-11 | Astex Therapeutics Ltd | Compuestos farmaceuticos. |
GB0505219D0 (en) * | 2005-03-14 | 2005-04-20 | Novartis Ag | Organic compounds |
JP2008540685A (ja) * | 2005-05-19 | 2008-11-20 | シーブイ・セラピューティクス・インコーポレイテッド | A1アデノシンレセプターアゴニスト |
US7381714B2 (en) * | 2005-05-19 | 2008-06-03 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
CA2625783A1 (en) * | 2005-10-13 | 2007-04-26 | Elfatih Elzein | A1 adenosine receptor agonists |
WO2007120972A2 (en) | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
US7589076B2 (en) * | 2006-05-18 | 2009-09-15 | Pgx Health, Llc | Substituted aryl piperidinylalkynyladenosines as A2AR agonists |
US8188063B2 (en) | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
DE102007012645A1 (de) | 2007-03-16 | 2008-09-18 | Bayer Healthcare Ag | Substituierte Imidazo- und Triazolopyrimidine |
EP2142546B1 (de) | 2007-03-28 | 2017-06-07 | Saniona A/S | Purinylderivate und ihre verwendung als kaliumkanalmodulatoren |
ZA200905796B (en) * | 2007-03-28 | 2010-10-27 | Neurosearch As | Purinyl derivatives and their use as potassium channel modulators |
US20090088403A1 (en) * | 2007-05-07 | 2009-04-02 | Randy Blakely | A3 adenosine receptors as targets for the modulation of central serotonergic signaling |
EP2200615A1 (de) * | 2007-10-16 | 2010-06-30 | Gilead Palo Alto, Inc. | A3-adenosinrezeptorantagonisten |
US8058259B2 (en) | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
RU2451010C1 (ru) * | 2011-01-11 | 2012-05-20 | Закрытое Акционерное Общество "Ива Фарм" | Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия |
BR112014032501A2 (pt) | 2012-06-26 | 2017-06-27 | Saniona Aps | composto, e, composição farmacêutica. |
WO2014138485A1 (en) * | 2013-03-08 | 2014-09-12 | Irm Llc | Ex vivo production of platelets from hematopoietic stem cells and the product thereof |
CA3061893A1 (en) * | 2017-05-19 | 2018-11-22 | Alltech, Inc. | Selenium containing pharmaceutical agents, compositions, and methods relating thereto |
EP3988100A4 (de) * | 2019-06-21 | 2023-07-26 | Academy of Military Medical Sciences | Adenosinverbindung, pharmazeutisch annehmbares salz oder stereoisomerid davon und verwendung |
CN116783196A (zh) * | 2020-12-29 | 2023-09-19 | 浙江春禾医药科技有限公司 | A3腺苷受体激动剂及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
US6180615B1 (en) * | 1999-06-22 | 2001-01-30 | Cv Therapeutics, Inc. | Propargyl phenyl ether A2A receptor agonists |
US6214807B1 (en) * | 1999-06-22 | 2001-04-10 | Cv Therapeutics, Inc. | C-pyrazole 2A A receptor agonists |
-
2002
- 2002-08-05 US US10/212,896 patent/US20030078232A1/en not_active Abandoned
- 2002-08-06 CA CA002456744A patent/CA2456744A1/en not_active Abandoned
- 2002-08-06 EP EP02763415A patent/EP1414837B1/de not_active Expired - Lifetime
- 2002-08-06 AT AT02763415T patent/ATE307136T1/de not_active IP Right Cessation
- 2002-08-06 MX MXPA04001185A patent/MXPA04001185A/es active IP Right Grant
- 2002-08-06 AU AU2002327426A patent/AU2002327426C1/en not_active Ceased
- 2002-08-06 WO PCT/US2002/024696 patent/WO2003014137A1/en active IP Right Grant
- 2002-08-06 JP JP2003519086A patent/JP4357960B2/ja not_active Expired - Fee Related
- 2002-08-06 NZ NZ530976A patent/NZ530976A/en not_active IP Right Cessation
- 2002-08-06 RU RU2004106635/04A patent/RU2298557C2/ru not_active IP Right Cessation
- 2002-08-06 DK DK02763415T patent/DK1414837T3/da active
- 2002-08-06 PL PL02368205A patent/PL368205A1/xx not_active Application Discontinuation
- 2002-08-06 IL IL16023102A patent/IL160231A0/xx unknown
- 2002-08-06 DE DE60206775T patent/DE60206775T2/de not_active Expired - Lifetime
- 2002-08-06 CN CNB02815486XA patent/CN1244589C/zh not_active Expired - Fee Related
- 2002-08-06 ES ES02763415T patent/ES2247371T3/es not_active Expired - Lifetime
- 2002-08-06 KR KR1020047001949A patent/KR100923888B1/ko not_active IP Right Cessation
- 2002-08-06 HU HU0401437A patent/HUP0401437A3/hu unknown
-
2004
- 2004-02-05 IL IL160231A patent/IL160231A/en not_active IP Right Cessation
- 2004-02-06 ZA ZA200401000A patent/ZA200401000B/en unknown
- 2004-03-05 NO NO20040969A patent/NO327997B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4357960B2 (ja) | 2009-11-04 |
AU2002327426A2 (en) | 2003-02-24 |
JP2005501842A (ja) | 2005-01-20 |
AU2002327426C1 (en) | 2008-03-06 |
ES2247371T3 (es) | 2006-03-01 |
CN1244589C (zh) | 2006-03-08 |
DK1414837T3 (da) | 2005-11-07 |
RU2004106635A (ru) | 2005-07-27 |
ATE307136T1 (de) | 2005-11-15 |
HUP0401437A3 (en) | 2007-05-29 |
AU2002327426B2 (en) | 2007-06-14 |
HUP0401437A2 (hu) | 2004-11-29 |
CN1538972A (zh) | 2004-10-20 |
EP1414837B1 (de) | 2005-10-19 |
EP1414837A1 (de) | 2004-05-06 |
NO20040969L (no) | 2004-04-19 |
KR20040023733A (ko) | 2004-03-18 |
PL368205A1 (en) | 2005-03-21 |
WO2003014137A1 (en) | 2003-02-20 |
RU2298557C2 (ru) | 2007-05-10 |
MXPA04001185A (es) | 2005-06-17 |
DE60206775T2 (de) | 2006-07-20 |
IL160231A0 (en) | 2004-07-25 |
KR100923888B1 (ko) | 2009-10-28 |
ZA200401000B (en) | 2004-10-18 |
NO327997B1 (no) | 2009-11-09 |
CA2456744A1 (en) | 2003-02-20 |
NZ530976A (en) | 2005-07-29 |
IL160231A (en) | 2010-11-30 |
US20030078232A1 (en) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60206775D1 (de) | Agonisten für den adenosin a3 rezeptor | |
CY1106424T1 (el) | Παραγωγα ν-φαινυλ-πυρρολ γουανιδινης ως συνδετες υποδοχεις μελανοκορτινης | |
ATE305932T1 (de) | Rapanycin29-enole | |
NO20041917L (no) | Spesifikke midler som binder humant angiopoietin-2 | |
BR0214870A (pt) | 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas e aplicação das mesmas | |
DK1472541T3 (da) | Afbildningsmidler og metoder til at afbilde NAALADase og PSMA | |
EA200500520A1 (ru) | Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов | |
EA200301213A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
PT1444215E (pt) | Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina | |
SMAP200600024A (it) | 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosia | |
MXPA04000886A (es) | Derivados de triazolil-imidazopiridina y triazolilpurinas empledos como ligandos del receptor de adenosina a2a y su uso como medicamentos. | |
DK1450811T3 (da) | Forbindelser specifikke af adenosin A1- og A3-receptorer og anvendelser heraf | |
ATE418555T1 (de) | A2a-adenosinrezeptorantagonisten | |
DK1622908T3 (da) | Xanthin-derivater som A2B adenosin-receptor-antagonister | |
CY1106194T1 (el) | Θepαπευτικη αγωγη της δυσκινησιας | |
MA27094A1 (fr) | Derives triazolo-quinoline utiles en tant que ligands recepteurs d'adenosine. | |
PT1200400E (pt) | Derivados de pirrolidino-2,3,4-trion-3-oxina substituidas com eficacia como antagonistas do receptor nmda | |
DK1406927T3 (da) | Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose | |
WO2004022573A3 (en) | Adenosine a3 receptor agonists | |
DE60206599D1 (de) | Biotin-derivate und ihre konjugaten mit chelatierungsmitteln | |
ES2166045T3 (es) | Procedimiento para la preparacion de compuestos de 4,6-bis(ariloxi)pirimidina asimetricos. | |
TR200001622T2 (tr) | Asilatlı Hetero-Alisiklik Türevleri | |
DK1144423T3 (da) | Bis-terpyridin-platin(II)-komplekser | |
RU2000116332A (ru) | Антгельминтное средство | |
DE60203740D1 (de) | Luminacine analoge und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |